In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.
Dr. Elena Netchiporouk illustrates key considerations for diagnosing CSU at EADV 2025.

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).
Professor Matthias Augustin highlights the role of type 2 inflammation in chronic itch across distinct pruritic skin diseases and the cumulative burden of chronic itch and skin lesions in PN.

Dr. Hawkes highlights how Chronic Urticaria is a mast cell centric disease with moderate levels of spontaneous remission in patients.

Dr Hawkes provides an overview of the distinctive characteristics of wheals and angioedema in clinical manifestation

Learn how loss of smell in CRSwNP is a key symptom for both patients and providers.

Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life
This infographic explores the emerging concepts of disease activity, disease stability, and disease control in COPD.
Learn from Drs. Buchheit and Wagenmann as they discuss key patient traits that predict disease recurrence in CRSwNP.
Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.
